Lincoln Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Lincoln Pharmaceuticals has informed the stock exchanges that its trading window will remain closed starting April 1, 2026, until 48 hours after the declaration of its audited financial results for the quarter and financial year ended March 31, 2026. This is a standard compliance measure under SEBI's Insider Trading Regulations, 2015. During this period, all directors, senior management personnel, promoters, promoter group members, and connected persons are prohibited from trading in the company's shares. The exact date of the board meeting to approve the audited results has not yet been disclosed and will be communicated later.
This is a routine regulatory filing and does not directly affect the stock price. However, it signals that the company's full-year FY26 audited results are due soon, which may be a catalyst for price movement once announced.